Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
or subscribe and save 10% We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits
All research is sourced from PubMed-indexed journals for informational and educational purposes only
of Med+ members given the GLP-1 Success Program say it helped minimize side effects* increase in quality of life was experienced by Med+ members given the GLP-1 Success Program** weight loss among WW Med+ members given the GLP-1 Success Program, on average, after 6 months*** *Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss within the WW Clinic Program and participating in the GLP-1 companion nutrition program
A 2025 pilot study examined intravenous BPC-157 infusion in two healthy adults receiving doses up to 20 mg
